Exhaled Biomarker Detection Device

Analytical platform for identification and quantification of disease biomarkers. Enables early disease detection through analysis of specific biological markers.

A medical device used to measure nitric oxide and carbon dioxide levels in human exhaled breath. It supports both oral and nasal breathing modes with a measurement range of 1ppb to 3500ppb, enabling detection of airway inflammation and respiratory conditions.

Integrated biomarker solutions for accelerating research and clinical screening through advanced detection methodologies and real-time monitoring capabilities for disease assessment.

Breath test device measuring carbon monoxide levels to assess red blood cell lifespan and diagnose hemolysis. Supports clinical evaluation of anemia, jaundice, and abdominal pain through non-invasive exhaled air analysis.

Microfluidic systems designed for sensitive detection and quantification of disease biomarkers in biological samples for diagnostic and monitoring purposes.

Specialized detection module for biomedical signal processing and analysis. Provides quantitative measurement capabilities for clinical diagnostic applications.

Comprehensive urine biomarker detection system for early disease detection and prevention. Enables identification of specific proteins in urine samples for clinical diagnosis and patient monitoring.

Diagnostic system detecting nitric oxide in exhaled breath to evaluate airway inflammation and diagnose primary ciliary dyskinesia. Provides non-invasive assessment of respiratory tract conditions.

A breath analysis diagnostic system for measuring fractional exhaled nitric oxide levels, used to assess airway inflammation in respiratory diseases such as asthma. The platform integrates proprietary smart chip, smart algorithm, and smart manufacturing technologies for clinical and home-based testing.

Portable breath analyzer for non-invasive detection and measurement of volatile organic compounds and biomarkers in exhaled breath. Applicable in respiratory diagnostics, metabolic screening, and point-of-care testing environments. Provides rapid analysis with minimal patient preparation required.

Nanoparticle-based exhaled breath analysis system for disease screening and biomarker detection. Enables non-invasive respiratory and systemic disease evaluation. Integrated analysis algorithms for automated interpretation.

A range of diagnostic products based on breath analysis technology for various health conditions. The product line is designed for non-invasive disease screening and early detection.